Article
Early clinical and pre-clinical therapy development in Nemaline myopathy.
Expert opinion on therapeutic targets - 1 Oct 2022
Fisher Gemma, Mackels Laurane, Markati Theodora, Sarkozy Anna, Ochala Julien, Jungbluth Heinz, Ramdas Sithara, Servais Laurent
Abstract excerpt
INTRODUCTION: Nemaline myopathies (NM) represent a group of clinically and genetically heterogeneous congenital muscle disorders with the common denominator of nemaline rods on muscle biopsy. NEB and ACTA1 are the most common causative genes. Currently, available treatments are supportive. AREAS COVERED: We explored experimental treatments for NM, identifying at least eleven mainly pre-clinical approaches...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
